Elevance HealthNYSE: ELV

The healthcare sector is often considered a defensive play, with healthcare stocks to buy offering stability and growth potential even during economic downturns. The sector's strength is driven by an aging global population, rising healthcare expenditures, and advancements in medical technology.

Elevance Health's (ELV) performance benefits from new contract wins, a strong Carelon segment and recovering Medicaid business.

While it's never a bad time to look for healthcare stocks to buy, the privatization of Medicare has created some very prosperous businesses. As a result, it's not necessarily great for consumers.

INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health Foundation, the philanthropic arm of Elevance Health, today announces the expansion of its substance use disorder (SUD) grants through an additional $13.1 million in awards across 35 nonprofit organizations. Each program will address substance use disorder, focusing on improving access to care, quality of treatment, and youth prevention and early intervention. This third phase of grants is part of the three-year, $30 million commitment the Foundati.

Elevance Health (ELV) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

OLDWICK, N.J.--(BUSINESS WIRE)-- #insurance--AM Best has assigned the Long-Term Issue Credit Ratings of “bbb+” (Good) to Elevance Health, Inc.'s (Elevance Health) (Indianapolis, IN) newly issued $600 million, 5.15% senior unsecured notes, due 2029; $1 billion, 5.375% senior unsecured notes, due 2034 and $1 billion, 5.65% senior unsecured notes, due 2054. The outlook assigned to these Credit Ratings (ratings) is stable. The proceeds from these issues are expected to be used for general corporate purposes, in.

Elevance (ELV) continues to focus on increasing shareholder value with consistent dividend payouts and stock repurchases.